Regulating insulin secretion by increasing insulin secretion from the pancreas in a glucose-dependent manner and increasing insulin-sensitivity in both alpha and beta cells Regulating glucagon secretion by decreasing glucagon secretion from the pancreas by engagement of a specific G protein-coupled receptor
Some patients report gastrointestinal side effects, such as nausea and discomfort, which can affect medication adherence and ultimately, the success of the treatment
Myogenic differentiation quantified through real-time PCR showing increased MyoD and myogenin expression
Because both medications influence appetite hormones, clinicians usually recommend careful timing and dose planning when switching treatments
Among the most notable in refractory cGvHD, one trial is evaluating Treg enriched cell infusions (NCT05095649), and one is assessing hydrogen water, previously assessed in adult patients as a feasible and active approach with extreme safety (NCT02918188) (Table 5)
The company has faced regulatory scrutiny
